|
On (b)(6) 2026, fresenius received a medwatch form 3500a regarding this 71-year-old female patient with end stage renal disease (esrd) on hemodialysis (hd) utilizing a fx coral fx80 hf dialyzer for renal replacement therapy (rrt) reportedly experienced an allergic/hypersensitivity reaction during hd therapy on (b)(6) 2026.The medwatch indicates the patient arrived at the outpatient dialysis clinic for her scheduled hd treatment on (b)(6) 2026.The patient¿s pre-treatment vital signs were as follows :blood pressure (bp = 171/76, pulse = 70, respirations = 19, temperature = 97.6.The patient was reportedly trialing a new type of dialyzer (fx coral fx80 hf dialyzer), and treatment began at 12:39 (b/p = 159/58, pulse = 68).However, after approximately 1-hour and 45 minutes (14:07) into treatment (b/p = 196, pulse = 73) the patient complained of mild generalized itchiness itchy eyes, body, face, back and chest discomfort.The staff documented the presence of angioedema, and the patient was medicated with intravenous push (ivp) benadryl 50 mg, pepcid (dosage, route not provided), and intramuscular (im) solu medrol 125 mg, as well as supplemental oxygen (2 liters).Additionally, the patient¿s treatment was terminated (estimated blood loss = 250 ml), and the extracorporeal blood was not returned.Emergency medical services (ems) were contacted, and the patient was transported to the emergency room for further evaluation.The patient remained alert and oriented throughout the serious adverse events, and her symptoms improved in the er.An electrocardiogram (ekg) was obtained (baseline), a chest x-ray (negative) and the patient¿s elevated troponin level was considered unremarkable given her esrd status.The patient was discharged home and returned for her next scheduled outpatient hd treatment on 25/jul/2026 and tolerated the treatment without incident utilizing a nipro 17h dialyzer.
|